Document Detail

Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo.
MedLine Citation:
PMID:  9382809     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: The transcriptional activation function of the p53 tumour suppressor protein is induced by DNA damage and results in growth arrest and/or apoptotic responses. A key component of this response is the dramatic rise in p53 protein concentration resulting from an increase in the protein's stability. Very recently, it has been suggested that interaction with the Mdm2 protein may target p53 for rapid degradation. We have designed a gene encoding a small protein that binds tightly to the p53-binding pocket on the Mdm2 protein. We have constructed the gene by cloning a phage display optimised Mdm2-binding peptide into the active-site loop of thioredoxin. RESULTS: When introduced into cells containing low levels of wild-type p53, this protein causes a striking accumulation of the endogenous p53 protein, activation of a p53-responsive reporter gene, and cell cycle arrest mimicking the effects seen in these cells after exposure to UV or ionising radiation. Microinjection of a monoclonal antibody to the p53-binding site on Mdm2 achieves a similar effect, establishing its specificity. CONCLUSIONS: These results demonstrate that the p53 response is constitutively regulated in normal cells by Mdm2 and that disruption of the interaction alone is sufficient to stabilise the p53 protein and activate the p53 response. Our mini protein approach provides a powerful new method to activate p53 without causing DNA damage. More broadly, it establishes a powerful general method for determining the biological consequences of the specific disruption of protein-protein interactions in cells.
A Böttger; V Böttger; A Sparks; W L Liu; S F Howard; D P Lane
Related Documents :
11287579 - Analyses of single-amino-acid substitution mutants of adenovirus type 5 e1b-55k protein.
18438429 - Proteomic identification of p53-dependent protein phosphorylation.
15848909 - Absence of prognostic significance of p21(waf1/cip1) protein expression in non-small ce...
12460759 - Protein mutagenesis with monodispersity-based quality probing: selective inactivation o...
21540829 - Lipid vesicle-mediated affinity chromatography using magnetic activated cell sorting (l...
17184779 - Identification of differential proteins in nasopharyngeal carcinoma cells with p53 sile...
12012339 - Expanding the nitrogen regulatory protein superfamily: homology detection at below rand...
21402099 - Proteomic identification of carbonylated proteins in 1,3-dinitrobenzene neurotoxicity.
15866939 - Genetic dissection of the sporulation protein spoiie and its role in asymmetric divisio...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Current biology : CB     Volume:  7     ISSN:  0960-9822     ISO Abbreviation:  Curr. Biol.     Publication Date:  1997 Nov 
Date Detail:
Created Date:  1998-02-25     Completed Date:  1998-02-25     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9107782     Medline TA:  Curr Biol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  860-9     Citation Subset:  IM    
Cancer Research Campaign Laboratories, University of Dundee, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amino Acid Sequence
Binding, Competitive
Cell Cycle / drug effects,  genetics
Cell Line
Molecular Sequence Data
Nuclear Proteins*
Prostate / cytology
Protein Binding / drug effects,  genetics
Protein Engineering / methods*
Proto-Oncogene Proteins / antagonists & inhibitors,  chemical synthesis*,  genetics,  metabolism,  pharmacology*
Proto-Oncogene Proteins c-mdm2
Recombinant Fusion Proteins / biosynthesis,  chemical synthesis,  physiology
Thioredoxins / genetics
Transcriptional Activation
Tumor Cells, Cultured
Tumor Suppressor Protein p53 / antagonists & inhibitors,  biosynthesis*,  genetics,  physiology
Reg. No./Substance:
0/Nuclear Proteins; 0/Proto-Oncogene Proteins; 0/Recombinant Fusion Proteins; 0/Tumor Suppressor Protein p53; 52500-60-4/Thioredoxins; EC protein, human; EC protein, mouse; EC Proteins c-mdm2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Color appearance depends on the variance of surround colors.
Next Document:  Translational attenuation mediated by an mRNA intron.